Bhagwan Yadav - Concepedia

Author

Bhagwan Yadav

Also Known As

B Yadav, B. Yadav, Balkrishnan Yadav, Bhagwan Yadav, Bhagwan Yadav (458005), Janneke Weiss, Marjan Weiss, Yadav Bhagwan, Yadav, Bhagwan

130

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Institute for Molecular Medicine Finland Helsinki University Hospital University of Turku University of Bergen

About

Bhagwan Yadav is an author at University of Helsinki specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.6K
2	Engineering	1	1	95
3	Natural Sciences	1	1	11
4	Biomolecular Engineering	1	1	95
5	Biostatistics	1	1	830

Bhagwan Yadav

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model Bhagwan Yadav, Krister Wennerberg, Tero Aittokallio, Computational and Structural Biotechnology Journal Drug TargetInteraction PotencyPharmacotherapyPharmacodynamic ModelingDrug Resistance	2015	830
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia Tea Pemovska, Mika Kontro, Bhagwan Yadav, Cancer Discovery	2013	401
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies Bhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, Scientific Reports	2014	357
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen Michael P. Menden, Dennis Wang, Mike J. Mason, Nature Communications	2019	350
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia Disha Malani, Ashwini Kumar, Oscar Brück, Cancer Discovery	2021	182
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia Heikki Kuusanmäki, Aino‐Maija Leppä, Petri Pölönen, Haematologica	2019	176
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells Otto Kauko, Caitlin M. O’Connor, Evgeny Kulesskiy, Science Translational Medicine Cell SignalingMedicineReceptor Tyrosine KinasePharmacologyKinase Inhibitors	2018	152
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target Olli Dufva, Matti Kankainen, Tiina Kelkka, Nature Communications	2018	139
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML Riikka Karjalainen, Tea Pemovska, Mihaela Popa, Blood	2017	120
Breeze: an integrated quality control and data analysis application for high-throughput drug screening Swapnil Potdar, Aleksandr Ianevski, John-Patrick Mpindi, Bioinformatics	2020	107

Page 1